Sandoz Omeprazol 20 mg gastro-resistant capsules

Sandoz Omeprazol is a widely used generic pharmaceutical product designed to treat acid-related conditions such as heartburn and acid reflux. The brand Sandoz has a deep history in the pharmaceutical industry, dating back to 1886 in Switzerland. It is recognized globally as a leader in generic and biosimilar medicines.

While the brand originated in Switzerland as part of the chemical and pharmaceutical boom in the late 19th century, its ownership has evolved significantly. Sandoz was a founding pillar of Novartis following its merger with Ciba-Geigy in 1996. However, in late 2023, Sandoz was successfully spun off from Novartis to become a fully independent, publicly traded company. Manufacturing for products like Omeprazol occurs across a global network of facilities, primarily focused in Europe to serve the Swedish and broader Scandinavian markets where this specific packaging is distributed.